New cancer clinical trial: Galinpepimut-S in Combination With Pembrolizumab in Patients With Selected Advanced Cancers

Published on: December 03, 2018 at 12:00PM
Conditions:   Acute Myelogenous Leukemia;   Ovarian Cancer;   Colorectal Cancer;   Triple-negative Breast Cancer;   Small-cell Lung Cancer
Interventions:   Biological: galinpepimut-S;   Drug: Pembrolizumab
Sponsors:   Sellas Life Sciences Group;   Merck Sharp & Dohme Corp.;   Cancer Insight, LLC
Not yet recruiting
https://ift.tt/2QvkhQt